Jiangsu Hengrui Medicine
600276.SS
#527
Rank
NZ$86.39 B
Marketcap
NZ$13.02
Share price
0.29%
Change (1 day)
-15.48%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): NZ$0.15

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is NZ$0.27. In 2022 the company made an earnings per share (EPS) of NZ$0.16 a decrease over its 2021 EPS that were of NZ$0.20.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$0.15-8.55%
2022NZ$0.16-17.1%
2021NZ$0.20-24.44%
2020NZ$0.2620.3%
2019NZ$0.2225.58%
2018NZ$0.1727.55%
2017NZ$0.1421.64%
2016NZ$0.1113.57%
2015NZ$0.0982539.86%
2014NZ$0.0702521.33%
2013NZ$0.0579017.7%
2012NZ$0.0491925.56%
2011NZ$0.0391826.22%
2010NZ$0.0310410.3%
2009NZ$0.0281457.92%
2008NZ$0.0178211.06%
2007NZ$0.0160485.81%
2006NZ$0.00863587.94%
2005NZ$0.00459433.97%
2004NZ$0.00342929.78%
2003NZ$0.00264219.78%
2002NZ$0.002206